— Know what they know.
Not Investment Advice
Also trades as: HVO.L (LSE) · $vol 0M

OPORF OTC

hVIVO plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +27.3% 1Y: -54.3% 3Y: -25.6% 5Y: -79.1%
$0.11
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 41 · $75.4M mcap · 659M float · 0.0001% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$63M +11.9% ▲
5Y CAGR: +80.4%
Gross Profit
$63M +381.1% ▲
Operating Income
$13M +27.3% ▲
Net Income
$11M -33.9% ▼
EPS (Diluted)
$0.02 -34.0% ▼
EBITDA
$18M +27.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$21M$37M$51M$56M$63M
YoY Growth+527.3%+78.9%+37.5%+10.5%+11.9%
Cost of Revenue$727K$963K$42M$46M$0
Gross Profit$20M$36M$9M$13M$63M
Gross Margin96.5%97.4%17.9%23.3%100.0%
R&D Expenses$0$0$82K$0$0
SG&A Expenses$11M$18M$24M$24M$26M
Operating Expenses$30M$2M$3M$3M$50M
Operating Income-$10M$590K$6M$10M$13M
Operating Margin-49.8%1.6%11.9%18.0%20.5%
Interest Expense$374K$227K$133K$155K$955K
Income Before Tax-$11M$277K-$365K$11M$13M
Tax Expense-$372K$351K$411K-$5M$3M
Net Income-$11M-$74K-$776K$16M$11M
Net Margin-52.4%-0.2%-1.5%28.8%17.0%
EPS (Diluted)$-0.02$-0.00$-0.00$0.02$0.02
EBITDA-$9M$3M$7M$14M$18M
Shares Outstanding600M670M671M686M688M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms